Department of Medicine, Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA.
Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Am J Hypertens. 2024 Jul 15;37(8):580-587. doi: 10.1093/ajh/hpae046.
Nearly half of all Americans have hypertension, and Black adults experience a disproportionate burden. Hypercoagulability may relate to hypertension risk, and higher levels of factor VIII increase thrombosis risk. Black adults have higher factor VIII and more hypertension than other groups. Whether higher factor VIII associates with incident hypertension is unknown.
The Biomarkers as Mediators of Racial Disparities in Risk Factors (BioMedioR) study measured certain biomarkers in a sex-race stratified sample of 4,400 REGARDS participants who attended both visits. We included BioMedioR participants, excluding those with prevalent hypertension, missing factor VIII level, or covariates of interest. Modified Poisson regression estimated risk ratios (RR) for incident hypertension by higher log-transformed factor VIII level per SD (SD of log-transformed factor VIII, 0.33). Weighting was applied to take advantage of REGARDS sampling design.
Among the 1,814 participants included (55% female, 24% Black race), the median follow-up was 9.5 years and 35% (2,146/6,138) developed hypertension. Black participants had a higher median (IQR) factor VIII level (105.6%; 87.1%-126.9%) than White participants (95.6%; 79.8%-115.9%; P < 0.001). The age- and sex-adjusted Black-White hypertension RR was 1.45 (95% CI 1.28, 1.63). Higher factor VIII was not associated with more hypertension (final model RR 1.01; 95% CI 0.94, 1.07).
In a prospective study of Black and White adults without prevalent hypertension, factor VIII was not associated with greater hypertension risk.
近一半的美国人患有高血压,而黑人成年人所受的负担不成比例。血液高凝状态可能与高血压风险有关,VIII 因子水平升高会增加血栓形成风险。黑人成年人的 VIII 因子水平较高,且高血压患病率高于其他群体。VIII 因子水平升高是否与高血压的发生有关尚不清楚。
生物标志物作为危险因素中种族差异的介导物(BioMedioR)研究在 REGARDS 研究中,对参加了两次随访的 4400 名 REGARDS 参与者的性别和种族分层样本中测量了某些生物标志物。我们纳入了 BioMedioR 参与者,但排除了那些存在高血压前期、VIII 因子水平缺失或其他感兴趣的协变量的参与者。采用经对数转换后的 VIII 因子水平每标准差(SD)(对数转换后的 VIII 因子 SD,0.33)来估计更高水平的 log 转换 VIII 因子与新发高血压的风险比(RR)。采用加权法来充分利用 REGARDS 抽样设计。
在纳入的 1814 名参与者中(55%为女性,24%为黑人),中位随访时间为 9.5 年,有 35%(2146/6138)发生高血压。黑人参与者的 VIII 因子水平中位数(IQR)较高(105.6%;87.1%-126.9%),高于白人参与者(95.6%;79.8%-115.9%;P<0.001)。经年龄和性别调整后,黑人-白人高血压 RR 为 1.45(95% CI 1.28,1.63)。更高的 VIII 因子水平与更多的高血压无关(最终模型 RR 1.01;95% CI 0.94,1.07)。
在一项对无高血压前期的黑人和白人成年人的前瞻性研究中,VIII 因子与更高的高血压风险无关。